HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
Open Access
- 2 March 2005
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 102 (11), 4134-4139
- https://doi.org/10.1073/pnas.0409500102
Abstract
Allopurinol, a commonly prescribed medication for gout and hyperuricemia, is a frequent cause of severe cutaneous adverse reactions (SCAR), which include the drug hypersensitivity syndrome, Stevens–Johnson syndrome, and toxic epidermal necrolysis. The adverse events are unpredictable and carry significant morbidity and mortality. To identify genetic markers for allopurinol–SCAR, we carried out a case-control association study. We enrolled 51 patients with allopurinol–SCAR and 228 control individuals (135 allopurinol-tolerant subjects and 93 healthy subjects from the general population), and genotyped for 823 SNPs in genes related to drug metabolism and immune response. The initial screen revealed strong association between allopurinol–SCAR and SNPs in the MHC region, including BAT3 (encoding HLA-B associated transcript 3), MSH5 (mutS homolog 5), and MICB (MHC class I polypeptide-related sequence B) (P < 10–7). We then determined the alleles of HLA loci A, B, C, and DRB1. The HLA-B*5801 allele was present in all (100%) 51 patients with allopurinol–SCAR, but only in 20 (15%) of 135 tolerant patients [odds ratio 580.3 (95% confidence interval, 34.4–9780.9); corrected P value = 4.7 × 10–24] and in 19 (20%) of 93 of healthy subjects [393.51 (23.23–6665.26); corrected P value = 8.1 × 10–18]. HLA alleles A*3303, Cw*0302, and DRB1*0301 were in linkage disequilibrium and formed an extended haplotype with HLA-B*5801. Our results indicated that allopurinol–SCAR is strongly associated with a genetic predisposition in Han Chinese. In particular, HLA-B*5801 allele is an important genetic risk factor for this life-threatening condition.Keywords
This publication has 37 references indexed in Scilit:
- A marker for Stevens–Johnson syndromeNature, 2004
- An Integrated Haplotype Map of the Human Major Histocompatibility ComplexAmerican Journal of Human Genetics, 2003
- Association of HLA Class I and II Alleles and Extended Haplotypes With Nasopharyngeal Carcinoma in TaiwanJNCI Journal of the National Cancer Institute, 2002
- Relation between adverse events associated with allopurinol and renal function in patients with goutAnnals Of The Rheumatic Diseases, 2001
- Blased Tests of Association: Comparisons of Allele Frequencies when Departing from Hardy-Weinberg ProportionsAmerican Journal of Epidemiology, 1999
- HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes.JCI Insight, 1998
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisThe New England Journal of Medicine, 1995
- The Spectrum of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Clinical Classification.Journal of Investigative Dermatology, 1994
- Asymptomatic hyperuricaemia and allopurinol induced toxic epidermal necrolysis.BMJ, 1985
- Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromiseArchives of Internal Medicine, 1974